1 |
Health insurance Review & Assesment service http://www.hira.or.kr/
|
2 |
www.cancer.go.kr/
|
3 |
M. Middendorp, F. Grunwald. "Update on recent evel opments in the therapy of differentiated thyroid cancer," J Seminars in nuclear medicine. Vol.40 No. 3, pp 145-152, 2010.
DOI
|
4 |
D. Aio, C. Giliberti, M. Benassi, L. Strigari, "Poten tial Third-party Radiation Exposure from Patients Undergoing Therapy with I-131 for Thyroid Cancer or Metastases," J of health physics. Vol. 108 No. 3, pp 145-152, 2015
DOI
|
5 |
E. Lubin, "Definitive improment in the approach to the treated patient as a radioactive source," J Nucl Med, Vol 43, No. 3, pp 364-5, 2002.
|
6 |
J. A. Siegel, C. S. Marcus, R. B. Sparks. "Calculating the absorbed dose from radioactive patients: the line source versus point source model," J Nucl Med Vol. 43, No. 9, pp 124-4, 2002.
|
7 |
S. G. Park "Suggestion of A Practical Simple Calculation Method for Safe Transportation Time after Radioactive Iodine Treatment in Patients with Thyroid Cancer", J of Korea Academy Industrial Cooperation Society, Vol 16, No 6, pp 3919-3925, 2015.
DOI
|
8 |
B. S. Chang "The Study and Measurement of Three Dimensional Spatial Dose Rate from Radioiodine Therapy," J of the Korean Society of Radiology. Vol 7, No 3, pp 251-257, 2013.
DOI
|
9 |
C. Franzius, M. Dietlein, M. Biermann, M. Fruhwald, T. Linden, P. Bucsky, "Procedure guide line for radioiodine therapyand 131 Iodine whole-body scinti graphy in paediatric patients with differentiated thyroid cancer," J of Nuklear medizin. Vol. 46, No. 5, pp. 224-31, 2007.
|
10 |
Republic of Korea Nuclear Safety Commission Notice, No 2012-69, 2012.
|
11 |
ICRP Publication 94, Release of patients after therapy with unsealed radionuclides, ICRP 34. pp 53-58, 2004.
|
12 |
Republic of Korea Nuclear Safety Commission Notice, No 2017-44, 2017.
|
13 |
K. Rothkamm, L.Markus, "Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses," J Proceedings of the National Academy of Sciences, Vol 100, No 9, pp 5057-5062, 2003.
DOI
|
14 |
ICRP Publication 105: Radiological Protection in Medicine, 1CRP, Vol.37. No. 6, 2007.
|
15 |
M. Luster, S. E Clarke, M. Dietlein, M. Lassmann, "Guidelines for radioiodine therapy of differentiated thyroid cancer," Eur J Nucl Med Mol Imaging Vol. 35, No. 10, pp. 1941-59, 2008.
DOI
|